openPR Logo
Press release

miRNA Tools and Services Market By Top Key Players QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., GeneCopoeia, Inc., Promega Corporation, Merck & Co., Inc. and Many Others.

04-24-2019 07:13 PM CET | Health & Medicine

Press release from: Allied Market Research

miRNA Tools and Services Market

miRNA Tools and Services Market

miRNA Tools and Services Market was valued at $146 million in 2015 and is expected to garner $620 million by 2022, registering a CAGR of 23.4% during the forecast period 2016 - 2022. The market is expected to witness significant growth owing to the rise in incidence of cancer and cardiovascular diseases. Moreover, use of bioinformatics and technologically advanced systems (such as NGS) are set to drive the market growth and the potential of miRNAs to act as candidates for diagnostic biomarkers are anticipated to further contribute to the demand for miRNA globally. However, the challenges related to quantification and the development of in-house miRNA research tools such as microarrays are expected to impede the market growth.

Increased funding by government and private organizations such as NIH is expected to drive the market growth. This is due to the large number of research projects undertaken to prove the therapeutic and diagnostic potential of miRNAs.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2103

MicroRNAs(miRNAs) are a class of non-coding RNAs that play a major role in regulating gene expressions. These molecules work at the post-transcription level and modify the expression of around 30% of all mammalian protein-encoding genes. Use of bioinformatics and technologically advanced systems (such as NGS) and rise in incidence of chronic disorders drive the market growth. In addition, the ability of miRNAs to act as diagnostic biomarkers and predictors of drug response are anticipated to drive the demand for miRNA. However, the challenges related to the quantification and the development of in-house miRNA research tools such as microarrays restrict the market growth.

The qRT-PCR technology segment is expected to maintain its dominant position throughout the analysis period due to the increase in incidence of chronic diseases such as cancer and cardiovascular disorders. The rise in demand for the identification of miRNA in different organisms and their associated role as a diagnostic biomarker for the disease also boost the market growth.

Research and academic institutes segment dominated the market with more than two-fifths of the total market in 2015. This is primarily attributed to the increase in research projects undertaken to test the ability of miRNA as candidates of disease biomarkers.

Key Findings of the Study:

• Research tools led the global miRNA tools and services market, and accounted for nearly four-fifths of the total market in 2015.
• Functional studies services segment is projected to grow at highest CAGR of 31.2% during the forecast period.
• CROs is the fastest growing segment and is expected to grow at a CAGR of 27.4% during the forecast period.
• qRT-PCR technology segment occupied nearly one-third of the market in 2015.
• In 2015 Japan was the major shareholder and accounted for almost one-third of the Asia-Pacific market.

Get More Informaion @ https://www.alliedmarketresearch.com/purchase-enquiry/2103

North America led the overall market in 2015 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increased funding for miRNA research and increase in incidence of chronic disorders such as cancer. However, Asia-Pacific is projected to be the fastest growing region throughout the analysis period owing to increase in investment by pharma and biotech companies in the emerging markets (such as India and China).

The major companies profiled in the report include QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., GeneCopoeia, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Merck & Co., Inc., and New England Biolabs.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. TOP PLAYER POSITIONING
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increasing incidence of cancer and cardiovascular disorders
3.4.1.2. Increased research funding for miRNA
3.4.2. Restraints
3.4.2.1. Development of in-house tools reduces commercial consumption
3.4.2.2. Challenges in the quantification of miRNA
3.4.3. Opportunities
3.4.3.1. Application of miRNA technology
3.4.3.1.1. miRNA biomarkers
3.4.4. Impact analysis
3.5. CLINICAL TRIALS

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/mirna-tools-and-services-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release miRNA Tools and Services Market By Top Key Players QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., GeneCopoeia, Inc., Promega Corporation, Merck & Co., Inc. and Many Others. here

News-ID: 1716666 • Views: 635

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for RNAs

Global Epigenetics Drugs and Diagnostic Technologies Market Analysis Revealing K …
The following research report is a compilation of high-end data that has been researched thoroughly to highlight the various trends prevailing across the Epigenetics Drugs and Diagnostic Technologies market. This study is titled “Global Epigenetics Drugs and Diagnostic Technologies Market Research Report 2019”, which carefully examines several vital factors such as market share, market revenue, market dynamics and competitive scenario active in the target market for the period between 2019
Cardior Receives EUR 1.01 Million Grant to Identify Novel Oligonucleotides for t …
- Collaboration with Hannover Medical School (MHH) Hanover, Germany, December 11, 2018 - Cardior Pharmaceuticals GmbH, a company focused on the development of noncoding RNA (ncRNA) therapeutics for patients with myocardial infarction and heart failure, today announced it has been granted EUR 1.01 million funding for a joint research project with the Institute of Molecular and Translational Therapeutic Strategies (IMTTS) at Hannover Medical School (MHH). Goal of the project is the
Targeted RNA Sequencing Market Report Explored in Latest Research 2016 - 2024
RNA sequencing (RNAseq) is a common tool for measuring relative gene expression levels. It is a versatile method that can be utilized to detect and characterize gene expression, mutations, gene fusions, and noncoding RNAs. Targeted RNA sequencing is a highly accurate method for selecting and sequencing specific transcripts of interest that offer both quantitative and qualitative information. Targeted RNA sequencing is a sequencing-based gene expression profiling method that allows
Small interfering RNA Therapeutics Market to Expand with Significant CAGR by 202 …
Small interfering RNA (siRNA) is a type of genetic medicine, which has potential to silence or knock down any over-expressed gene in a disease. It is also called short interfering RNA. These RNAs are widely used to evaluate the specific contribution of genes to a variety of cellular phenotypes including apoptosis, insulin signaling, cytokinesis, and cell differentiation. They are employed to recognize novel pathways and have a meaningful impact in
Targeted RNA Sequencing Market is Expected to Witness a Steady Growth by 2024
RNA sequencing (RNAseq) is a common tool for measuring relative gene expression levels. It is a versatile method that can be utilized to detect and characterize gene expression, mutations, gene fusions, and noncoding RNAs.  Targeted RNA sequencing is a highly accurate method for selecting and sequencing specific transcripts of interest that offer both quantitative and qualitative information. Targeted RNA sequencing is a sequencing-based gene expression profiling method that allows quantification
Gene Expression Analysis Market Expected to Procure More than US$ 4,500 Mn Reven …
A latest research report titled as “Global Market Study on Gene Expression Analysis Market: Adoption of Northern Blotting Technology to Gain Widespread Traction through 2022” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders,